Back to search

Article

A Genetic Variant rs10251977 in Long Non-coding RNA EGFR-AS1 Creates a New Binding Site for miR-891b and Modulates the Expression of EGFR A/D Isoforms

2020-12-31

Abstract excerpt

Tyrosine kinase inhibitor (TKI) is one of the effective chemo-preventive approaches against tumors that deregulate EGFR pathway. About 80% of HNSCC patients overexpress EGFR, making TKI an effective treatment against this cancer. Recently a synonymous variant rs10251977 in exon 20 of EGFR reported to act as a prognostic marker in HNSCC. Analysis of this germline variant in blood samples of oral cancer patients sho...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7a94270a-a330-5e3c-b422-bfa7f0c882b4
DOI
10.21203/rs.3.rs-136285/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Genetic Variant rs10251977 in Long Non-coding RNA EGFR-AS1 Creates a New Binding Site for miR-891b and Modulates the Expression of EGFR A/D IsoformsDOI 10.21203/rs.3.rs-136285/v1
Select a neighboring publication to make it the new centre.